HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) All Versions of this Article: jmg.2007.055475v1 45/5/314    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Google Scholar Articles by Chabrol, B Articles by Creemers, J W M PubMed PubMed Citation Articles by Chabrol, B Articles by Creemers, J W M Pubmed/NCBI databases Gene GEO Profiles HomoloGene Nucleotide OMIM Protein UniGene Substance via MeSH Genetics Home Reference

Deletion of C2orf34, PREPL and SLC3A1 causes atypical hypotonia–cystinuria syndrome

¹ Reference Center for inborn metabolic disorders, CHU de la Timone, Marseille, France
² Laboratory for Biochemical Neuroendocrinology, Center for Human Genetics, University of Leuven, Belgium
³ Laboratory for Molecular Diagnosis, Center for Human Genetics, University of Leuven, Belgium
⁴ Center for Metabolic Disease, University of Leuven, Belgium

Correspondence to:
Dr J Creemers, Center for Human Genetics, University of Leuven, Gasthuisberg O/N 6, box 602, Herestraat 49, B-3000 Leuven; john.creemers{at}med.kuleuven.be]

ABSTRACT
Background: Hypotonia–cystinuria syndrome (HCS) and 2p21 deletion syndrome are two recessive contiguous gene deletion syndromes associated with cystinuria type I. The deletions differ in size and the number of genes involved. In HCS patients, only SLC3A1 and PREPL are disrupted. In the 2p21 deletion syndrome, two additional genes (C2orf34 and PPM1B) are lost.

Objective: Clinical and molecular analysis of two siblings who presented with an atypical HCS phenotype.

Methods: Molecular analysis of the SLC3A1/PREPL locus was performed in the patients using quantitative polymerase chain reaction (PCR) methods.

Results: HCS in both siblings was confirmed with the deletion screen of the SLC3A1/PREPL locus. Fine mapping of the breakpoint revealed a deletion of 77.4 kb, including three genes: SLC3A1, PREPL and C2orf34. Features not present in classical HCS were a mild/moderate mental retardation and a respiratory chain complex IV deficiency documented in patient 2.

Conclusions: We report the first patients with a deletion of SLC3A1, PREPL and C2orf34. They present with a phenotype intermediate between HCS and 2p21 deletion syndrome. These patients facilitate the elucidation of the contribution of each gene to the phenotype in the different 2p21 deletion syndromes.